{
  "ticker": "EW",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:33:46.038115",
  "count": 154,
  "transactions": [
    {
      "id": 8486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 19866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 34323,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 52492,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 73155,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 95939,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 120851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 147762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 8480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 19858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 34300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 52466,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 73126,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 95910,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 120822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 147733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 8482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 19860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 34302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 52468,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 73128,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 95912,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 120824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 147735,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 8469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34265,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52431,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73088,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95870,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120779,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 19849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52444,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73102,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 95884,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 120795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 147705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 8479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 19857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 34296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 52462,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 73122,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 95906,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 120818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 147729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 8475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 8481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 19852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 19859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 34281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 34301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 52447,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 52467,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 73105,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 73127,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 95888,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 95911,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 120800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 120823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 147711,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 147734,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 1587,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 8471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 19847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 34275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 52441,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 73098,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 95880,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 120791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 147701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 1591,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 1592,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 1593,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 8477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 8478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 8483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 19854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 19856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 19861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 34287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 34293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 34303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 52453,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 52459,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 52469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 73111,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 73118,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 73129,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 95894,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 95901,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 95913,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 120806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 120813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 120825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 147717,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 147724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 147736,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 1589,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 1590,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 8474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 8476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 19851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 19853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 34280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 34283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 52446,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 52449,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 73104,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 73107,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 95886,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 95890,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 120798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 120802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 147709,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 147713,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 1594,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 8484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 19862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 34307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 52473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 73134,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 95918,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 120830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 147741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 1588,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 8473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 19850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 34279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 52445,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 73103,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 95885,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 120796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 147707,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 1586,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52439,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73096,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95878,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147698,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 1595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 8485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 19865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 34317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 52486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 73148,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 95932,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 120844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 147755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    }
  ]
}